535
edits
Changes
no edit summary
|3.3*10<sup>2</sup>-5.0*10<sup>3</sup>
|-
|TheradiagBecton Dickinson & Co.<ref name=”[29]”"Arti19">LTA002 LISA-TRACKER Adalimumab (2017)Becton Dickinson & Co. RIDT Product Information, Becton Dickinson & Co. Leaflet ''LTA002 LISA-TRACKER Adalimumab'', https://www. Theradiagbd.com/en-us/offerings/capabilities/microbiology-solutions/point-of-care-testing/veritor-system</ref>|LTA 002BD Veritor™ Flu A + B|LISA-TRACKER AdalimumabYes|BD veritor plus Analyzer|5 μL83,6%|0.3 - 16 µg/mL97,5%|1:200NPS, NS direct|Intra-assay: CV < 133.3%*10<sup>2<br /sup>Inter-assay: CV5.0*10<sup>3< 9.7%|2 hours/sup>
|-
|R-Biopharm AG<ref name=”[30]”>GN3043 RIDA®QUICK ADM Monitoring (2018). Leaflet ''GN3043 RIDA®QUICK ADM Monitoring''. R-Biopharm AG.</ref>
